Follow
Jakob Moeller Hansen, MD, PhD, MSc
Jakob Moeller Hansen, MD, PhD, MSc
Neuroloy Practice Slagelse
Verified email at regionh.dk - Homepage
Title
Cited by
Cited by
Year
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
JM Hansen, AW Hauge, J Olesen, M Ashina
Cephalalgia 30 (10), 1179-1186, 2010
5052010
Guidelines for controlled trials of drugs in migraine: A guide for investigators
International Headache Society Clinical Trials Subcommittee members:, ...
Cephalalgia 32 (1), 6-38, 2012
3962012
Migraine and the trigeminovascular system—40 years and counting
M Ashina, JM Hansen, TP Do, A Melo-Carrillo, R Burstein, MA Moskowitz
The Lancet Neurology 18 (8), 795-804, 2019
3632019
Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list
TP Do, A Remmers, HW Schytz, C Schankin, SE Nelson, M Obermann, ...
Neurology 92 (3), 134-144, 2019
3042019
Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine
A Rahmann, T Wienecke, JM Hansen, J Fahrenkrug, J Olesen, M Ashina
Cephalalgia 28 (3), 226-236, 2008
3042008
Human models of migraine—short-term pain for long-term gain
M Ashina, JM Hansen, BO á Dunga, J Olesen
Nature Reviews Neurology 13 (12), 713-724, 2017
1932017
Migraine headache is present in the aura phase: a prospective study
JM Hansen, RB Lipton, DW Dodick, SD Silberstein, JR Saper, SK Aurora, ...
Neurology 79 (20), 2044-2049, 2012
1532012
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data
G Thomalla, F Boutitie, H Ma, M Koga, P Ringleb, LH Schwamm, O Wu, ...
The Lancet 396 (10262), 1574-1584, 2020
1372020
Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers
JM Hansen, J Sitarz, S Birk, AM Rahmann, PS Oturai, J Fahrenkrug, ...
Cephalalgia 26 (8), 992-1003, 2006
1172006
Pearls and pitfalls in human pharmacological models of migraine: 30 years' experience
M Ashina, JM Hansen, J Olesen
Cephalalgia 33 (8), 540-553, 2013
1132013
Opening of ATP-sensitive potassium channels causes migraine attacks: a new target for the treatment of migraine
MAM Al-Karagholi, JM Hansen, S Guo, J Olesen, M Ashina
Brain 142 (9), 2644-2654, 2019
1122019
Distinctive anatomical and physiological features of migraine aura revealed by 18 years of recording
JM Hansen, SM Baca, P VanValkenburgh, A Charles
Brain 136 (12), 3589-3595, 2013
1092013
Variability of clinical features in attacks of migraine with aura
JM Hansen, PJ Goadsby, AC Charles
Cephalalgia 36 (3), 216-224, 2016
962016
Functional connectivity studies in migraine: what have we learned?
K Skorobogatykh, WS Van Hoogstraten, D Degan, A Prischepa, ...
The journal of headache and pain 20, 1-10, 2019
822019
Calcitonin gene–related peptide does not cause the familial hemiplegic migraine phenotype
JM Hansen, LL Thomsen, J Olesen, M Ashina
Neurology 71 (11), 841-847, 2008
802008
Familial hemiplegic migraine type 1 shows no hypersensitivity to nitric oxide
JM Hansen, LL Thomsen, J Olesen, M Ashina
Cephalalgia 28 (5), 496-505, 2008
742008
Differences in treatment response between migraine with aura and migraine without aura: lessons from clinical practice and RCTs
JM Hansen, A Charles
The journal of headache and pain 20 (1), 96, 2019
692019
Migraine aura: new ideas about cause, classification, and clinical significance
A Charles, JM Hansen
Current opinion in neurology 28 (3), 255-260, 2015
652015
Familial hemiplegic migraine type 2 does not share hypersensitivity to nitric oxide with common types of migraine
JM Hansen, LL Thomsen, R Marconi, G Casari, J Olesen, M Ashina
Cephalalgia 28 (4), 367-375, 2008
652008
Dose‐response testing with nickel sulphate using the TRUE test® in nickel‐sensitive individuals. Multiple nickel sulphate patch‐test reactions do not cause an “angry back”
KE Andersen, C Liden, J Hansen, A Vøeund
British Journal of Dermatology 129 (1), 50-56, 1993
641993
The system can't perform the operation now. Try again later.
Articles 1–20